Showing all 2 results
Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration). Accurate low-dose titration is critical for modern therapy.
Active Ingredient Strength (Standard) Role Hydrochlorothiazide USP/BP 12.5 mg Initial Dose / Combination Use Hydrochlorothiazide USP/BP 25 mg Standard Therapeutic Dose Hydrochlorothiazide USP/BP 50 mg Edema / High Potency Excipients Q.S. Lactose (Filler) / Starch Torsemide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, providing dosage flexibility for both mild hypertension and severe renal failure.
Active Ingredient Strength Primary Clinical Use Torsemide USP/Ph.Eur. 5 mg / 10 mg Standard maintenance therapy for mild-to-moderate congestive heart failure and essential hypertension. Torsemide USP/Ph.Eur. 20 mg Acute diuresis for severe hepatic cirrhosis and advanced heart failure exacerbations. Torsemide USP/Ph.Eur. 100 mg High-dose therapy specifically reserved for patients with severe chronic renal failure (CRF) and massive fluid overload. Excipients Lactose Monohydrate / Crospovidone / Magnesium Stearate Diluent / Superdisintegrant / Lubricant (Engineered for immediate, predictable gastric dissolution)
